Molecular challenges of neuroendocrine tumors

Parthik Patel1, Karina Galoian1

  • 1Department of Orthopedic Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

Oncology Letters
|February 20, 2018
PubMed

Insights

Neuroendocrine tumors (NETs) are rare, heterogeneous cancers often diagnosed late. Novel therapeutic strategies are urgently needed due to the ineffectiveness of current treatments like chemotherapy and radiation.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Neuroendocrine tumors (NETs) are a diverse group originating from endocrine and nervous system cells.
  • NETs predominantly affect the gastrointestinal and pulmonary systems, often detected late with metastatic spread.
  • Conventional therapies (chemotherapy, radiation, surgery) show limited efficacy for advanced NETs, posing a significant clinical challenge.

Purpose of the Study:

  • To review current knowledge on the molecular underpinnings of NETs.
  • To explore the role of neuroendocrine cells, hormonal peptides, and neuropeptides in NET development.
  • To discuss epigenetic regulation and other complex questions in NET research.

Main Methods:

  • Literature review of accumulated knowledge on NETs.
  • Focus on molecular aspects, cellular origins, and hormonal dysregulation.
  • Examination of epigenetic factors and future research challenges.

Main Results:

  • NETs are characterized by heterogeneity and complex molecular signaling pathways.
  • Ectopic hormone production is a hallmark feature, contributing to diagnostic and therapeutic difficulties.
  • Limited understanding of NET biology hinders effective treatment development.

Conclusions:

  • NETs represent a significant unmet medical need requiring novel therapeutic approaches.
  • Further research into molecular mechanisms, including epigenetics, is crucial for advancing NET treatment.
  • A deeper understanding of NET biology is essential to improve patient survival rates.